Institute for Molecular Medicine

Founded in 1996, The Institute for Molecular Medicine is a non-profit 501(c)(3) research organization dedicated to discovering diagnostic and therapeutic solutions for chronic human diseases. The institute employs multidisciplinary research programs focusing on areas such as molecular immunology, virology, and pathology. Its scientific efforts include investigating the pathogenesis of complex conditions like autoimmune diseases, fatigue-related illnesses, cancer, neurodegenerative disorders, and various chronic infectious diseases. By bridging basic laboratory research with translational clinical programs, the institute aims to advance the understanding, prevention, and treatment of these catastrophic conditions.

The institute’s work is vital for patients and physicians seeking information on chronic illness etiology and potential diagnostic strategies. While it is not a clinical practice and does not treat patients directly, it conducts approved clinical trials and provides informational support to the medical community. The organization relies on scientific rigor, having published extensively in peer-reviewed medical journals regarding its research. Its operations are supported through grants, including those from the National Institutes of Health, and tax-deductible charitable contributions. Through these efforts, the institute serves as a resource for exploring the infectious and molecular underpinnings of illnesses that remain complex to diagnose and manage.